Author

Tedla Teferi Tego

Observed names: Tedla Teferi Tego, Tedla T. Tego, Tedla Teferi, Teferi, Tedla, Tego, Tedla Teferi

Institution: Arba Minch University

Observed institutions: Infectious Disease Research Institute, University of Khartoum, Arba Minch University, Addis Ababa University, University of Gondar

OpenAlex ID: A5048718850

Comparison of Point-of-Care Tests for the Rapid Diagnosis of Visceral Leishmaniasis in East African Patients

2014 · Asrat Bezuneh, Maowia Mukhtar, et al. · American Journal of Tropical Medicine and Hygiene · 46

Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial

2023 · Kamala Thriemer, Tamiru Shibiru Degaga, et al. · The Lancet · 31

Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trial

2026 · Tamiru Shibiru Degaga, Ayodhia Pitaloka Pasaribu, et al. · The Lancet Infectious Diseases · 14

Adapting international clinical trials during COVID-19 and beyond

2023 · Kamala Thriemer, Tamiru Shibiru Degaga, et al. · Clinical Trials · 8

Reducing the risk of Plasmodium vivax after falciparum infections in co-endemic areas—a randomized controlled trial (PRIMA)

2022 · Kamala Thriemer, Tamiru Shibru Degaga, et al. · Trials · 8

Disseminating clinical study results to trial participants in Ethiopia: insights and lessons learned

2020 · Tamiru S. Degaga, Sophie Weston, et al. · Malaria Journal · 8

Spliced-Leader RNA as a Dynamic Marker for Monitoring Viable Leishmania Parasites During and After Treatment

2024 · Rik Hendrickx, Roma Melkamu, et al. · The Journal of Infectious Diseases · 6

Effectiveness and Safety of High Dose Primaquine and Tafenoquine in Plasmodium vivax Patients (EFFORT) - A Multi-Centre, Open Label, Superiority Randomised Controlled Trial

2025 · Tamiru Shibiru Degaga, Ayodhia Pitaloka Pasaribu, et al. · SSRN Electronic Journal · 4

The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial

2023 · Kamala Thriemer, Robert James Commons, et al. · BMC Medical Research Methodology · 4

How do study participants want to be informed about study results: Findings from a malaria trial in Cambodia, Ethiopia, Pakistan, and Indonesia

2025 · Samuel Alemu Bamboro, Fareeha Abdul Jabbar, et al. · Journal of Clinical and Translational Science · 3

Impact of enhanced malaria surveillance processes and data feedback on data comprehensiveness and malaria case management in Arba Minch Zuriya District, Ethiopia: a pre-post implementation study

2026 · Tamiru Shibiru Degaga, Samuel Alemu Bamboro, et al. · Research Square

Works count: 17

Citation count: 132

H-index: 6

I10-index: 3